Applications of 1-(2,4-Dichlorophenyl)-2-(1H-Imidazole-1-Yl) Ethanone in Industrial Manufacturing

1-(2,4-Dichlorophenyl)-2-(1H-Imidazole-1-Yl) Ethanone is an essential intermediate in advanced specialty chemicals manufacturing, primarily supporting pharmaceutical, veterinary, and crop protection synthesis sectors. Our production supplies high-purity grade material used by formulation and process engineers for diverse downstream applications where imidazole derivatives and halogenated aromatics play a critical functional role. Below, we outline several industrial deployment scenarios, providing detailed information on compliance benchmarks, technical usage levels, process entry stages, and typical finished product categories for each segment.

1. Pharmaceutical Active Pharmaceutical Ingredient (API) Synthesis — Imidazole Antifungal Intermediates

Pharmaceutical producers rely on this molecule as a key intermediate in synthesizing second-generation imidazole antifungals for systemic and topical formulations. The integration into chemical synthesis chains supports strict multi-step GMP processes, where the structural moieties derived from this intermediate impart antifungal specificity and help meet regulatory requirements for impurity profiles. Downstream manufacturers use dedicated reaction steps that demand traceable origin, documented residual solvent levels, and rigorous batch record management to comply with human drug manufacturing controls.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• WHO GMP for pharmaceutical production
• European Pharmacopoeia (for intermediate input traceability)
• FDA CFR Title 21 Part 211 (for API manufacturing quality systems)

Typical usage ratio

• Reactant input range: 0.9–1.2 molar equivalents per batch, adjusted for target yield and impurity limits. Typical scale: 0.5–2% mass fraction in multistep synthesis workflow.

Downstream process integration

• Added during early to mid-stage heterocycle formation, often as the limiting reagent in N-alkylation or ketone condensation reactions prior to antifungal API finalization.

Final product types

• Clotrimazole, econazole, miconazole APIs and their corresponding tablets, creams, topical sprays.

2. Veterinary Drug Manufacturing — Imidazole-Based Antiparasitic Agents

Veterinary pharmaceutical processors make use of this intermediate to construct imidazole scaffolds essential to synthesis of antiparasitic and antifungal actives for animal health products. Commercial batch records require precise stoichiometric calculations to match species-specific dosing and impurity clearance for regulatory-approved veterinary ranges. The intermediate is handled in closed reactor systems with validated cleaning protocols to prevent cross-contamination due to tight residue limits for use in food-producing animals.

Industry compliance standards

• VICH GL guidelines on Good Manufacturing Practice for APIs used in Veterinary Drugs
• United States Pharmacopeia (USP) on veterinary drugs (reference standards where applicable)
• EMA CVMP Guidance on QP oversight for veterinary medicines
• China Veterinary Drug Administration GMP (2020 Edition)

Typical usage ratio

• Used at 1.0–1.15 equivalents in core synthesis of veterinary imidazole actives. Adjustments made based on downstream purification efficiency and impurity clearance needs.

Downstream process integration

• Introduced at the primary condensation or cyclization route leading to the veterinary API core. Critical control point for in-process monitoring to ensure batch-to-batch consistency.

Final product types

• Veterinary antifungal powders, oral pastes, topical suspensions, medicated animal feed additives.

3. Crop Protection Formulations — Imidazole-Derived Fungicide Manufacturing

Crop protection chemistry producers incorporate this molecule for constructing imidazole-derived fungicides targeting soilborne and foliar plant pathogens. Production lines maintain traceability per agrochemical industry stewardship, with technical concentrations optimized to maximize conversion to desired active moieties without off-target byproduct formation. Synthesis reactors are designed to accommodate high-volume throughput, and quality assurance teams monitor lot-to-lot purity to meet national pesticide registration guidelines.

Industry compliance standards

• FAO/WHO Specification for agricultural pesticides
• EPA 40 CFR Part 174/180 (US Environmental Protection Agency pesticide regulation)
• GB/T 1600-2016 (Chinese national standard for pesticide technical materials)
• REACH (EU Registration, Evaluation, Authorization and Restriction of Chemicals)

Typical usage ratio

• Active precursor input: 0.8–1.05 molar equivalents in technical grade fungicide synthesis. The precise amount confirmed by HPLC at key process stages to minimize unreacted starting material.

Downstream process integration

• Dosed during the base-mediated condensation/amination sequence forming the imidazole ring of the fungicidal active, preceding formulation into bulk concentrate or dispersible granule.

Final product types

• Agrochemical technical concentrates, wettable powders, suspension concentrates, seed treatment fungicide packs.

4. Specialty Chemical Intermediates — Development of Halogenated Imidazole Derivatives

Specialty fine chemicals manufacturers select this compound as a foundation block for custom synthesis of halogenated imidazole derivatives, which serve as reference materials, standards, and further intermediates in dye, pigment, and advanced research chemical synthesis. These downstream operations demand complete batch traceability, documented certificate of analysis by NMR/GC-MS, and integration into multistep processes that require isolation and purification at high concentration for structure-activity studies or further chemical elaboration.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems for specialty chemicals
• OECD Good Laboratory Practice (GLP) for test chemicals
• Internal analytical QC protocols as registered with national authorities
• Chemical Inventories: TSCA (US), EINECS (EU), IECSC (China)

Typical usage ratio

• Utilized at 1.0–1.3 molar equivalents in targeted synthesis runs, tailored based on the final derivative specification and required purity threshold for downstream chemical transformation.

Downstream process integration

• Introduced as a core reactant in the initial halogenation, substitution, or condensation step within custom research chemical synthesis sequences, with mid-process crystallization to achieve reference-grade standards.

Final product types

• Analytical reference standards, chemical probes, halogenated dye and pigment intermediates, research catalog compounds.